SafeSequence › UK Safety Template Library › Commercial Brand COSHH › Sika Sikaflex-11 FC+ & EBT Polyurethane Adhesive Sealant
Reference UK COSHH Example • Commercial Brand COSHH

Sika Sikaflex-11 FC+ & EBT Polyurethane Adhesive Sealant (COSHH Template & 5x5 Risk Assessment)

Under COSHH Regulations 2002 (as amended), REACH Diisocyanate Training Mandate (Regulation EU 2020/1149), and EH40/2005 Workplace Exposure Limits, Sika Sikaflex-11 FC+ & EBT polyurethane adhesive sealant (GHS07, H317 Skin Sensitiser Category 1) requires mandatory respiratory protection, skin contact prevention, local exhaust ventilation (LEV), and documented diisocyanate competency training to reduce dermal sensitisation and respiratory exposure risks from High (15-20) to Low (3-4) through engineering controls and strict isolation protocols.

Statutory FrameworkCOSHH Regulations 2002, REACH Diisocyanate Training Mandate, EH40/2005 WELs (GHS07, H317 Skin Sensitiser)
ClassificationGHS Classification: GHS07 Pictogram. H317 May cause an allergic skin reaction (Skin Sensitiser Category 1). H319 Causes serious eye irritation. Contains polymeric MDI (diphenylmethane diisocyanate). REACH Regulation (EU) 2020/1149 mandates documented diisocyanate training for industrial and professional use. EH40/2005 WEL for MDI: 0.02 mg/m³ (8-hour TWA). No UN classification for non-bulk packaging under ADR/RID. Product requires SDS Section 8 controls and occupational exposure monitoring where LEV is insufficient.
Required Plant / KitLocal Exhaust Ventilation (LEV) system with minimum 0.5 m/s capture velocity (HSG258 compliant) • Sealant application gun (pneumatic or manual cartridge dispenser) • Disposable polyethylene surface masking tape and sheeting • Isopropanol or approved solvent wipes for surface preparation and tool cleaning • Calibrated respiratory fit-testing equipment and particulate/organic vapour cartridge respirators (P3 + A2 filters)
Site Sign-Off StatusRequires Competent Person Verification
Instant AI Customization or Free Blank Word (.doc) Download

Need this COSHH customized with your Company Name, Site Postcode & Nearest A&E Hospital?

Dictate your site specifics on your phone in 45 seconds to auto-compile a signed PDF—or download our free blank Word (.doc) shell below.

Auto-Fill via Voice / CLP (45s)

1. Mandatory Personal Protective Equipment (BS EN Standards)

BS EN ISO 374-1:2016 Type B (KPT), BS EN 374-5:2016
Nitrile chemical-resistant gloves (minimum 0.38mm thickness, breakthrough time >480 minutes for isocyanates)
Prevent dermal contact with H317 skin sensitiser (polymeric MDI). Mandatory under COSHH Regulation 7 to eliminate skin sensitisation risk.
BS EN 140:1999, BS EN 143:2000 (P3), BS EN 14387:2004 (A2)
Full-face or half-mask respirator with combined P3 particulate and A2 organic vapour filters
Protect against MDI aerosol and vapour exposure below 0.02 mg/m³ WEL. Mandatory where LEV cannot achieve adequate control or during confined space application.
BS EN 166:2001 (1.F.3 or 1.B.3)
Safety spectacles with side shields or full-face visor
Prevent eye contact with H319 irritant. Mandatory under COSHH Regulation 7 and PPE at Work Regulations 1992.
BS EN ISO 13982-1:2004 (Type 5), BS EN 13034:2005 (Type 6), BS EN ISO 20345:2011 S3
Chemical-resistant coveralls (Type 5/6) and safety footwear with chemical-resistant soles
Prevent skin contamination during bulk application or spill scenarios. Required for prolonged or high-volume sealant application tasks.

2. 5×5 Hazard Risk Assessment Matrix (HASAWA 1974 / MHSWR 1999)

Identified Hazard & HarmInitial Risk (L×S)Mandatory Engineering, Isolation & Procedural ControlsResidual Risk
1. Dermal sensitisation from polymeric MDI (diphenylmethane diisocyanate) skin contact
Harm: Allergic contact dermatitis, chronic skin sensitisation, occupational asthma trigger, permanent sensitisation requiring medical surveillance and job restriction
4 × 4 = 16Eliminate skin contact: nitrile gloves BS EN ISO 374-1:2016 (>0.38mm, >480 min breakthrough). Pre-task skin checks. Immediate washing facilities within 5m. Barrier creams prohibited (HSG97). COSHH assessment review every 12 months. Occupational health surveillance (skin inspections) for all exposed workers. Documented glove change protocol every 2 hours or on visible contamination.2 × 2 = 4
2. Inhalation of MDI aerosol/vapour exceeding EH40/2005 WEL (0.02 mg/m³ 8-hour TWA)
Harm: Respiratory sensitisation, occupational asthma, bronchospasm, chronic obstructive pulmonary disease (COPD), permanent respiratory impairment requiring medical removal
4 × 5 = 20Engineering control hierarchy: LEV system (HSG258) with 0.5 m/s minimum capture velocity at source. LEV thorough examination and test (TExT) every 14 months by competent person (COSHH Regulation 9). Respiratory protection: BS EN 140 half-mask with P3+A2 filters where LEV insufficient. Quantitative fit-testing (QNFT) annually. Personal air monitoring (MDHS14/4) for initial exposure assessment and every 24 months. Restrict work to <2 hours without break. Prohibit eating/drinking/smoking in work area.2 × 2 = 4
3. Eye contact with uncured polyurethane sealant (H319 serious eye irritation)
Harm: Corneal abrasion, chemical conjunctivitis, temporary vision impairment, secondary infection risk, potential permanent eye damage if not irrigated immediately
3 × 3 = 9Mandatory eye protection: BS EN 166:2001 safety spectacles (1.F.3) with side shields or full-face visor during dispensing and application. Emergency eyewash station (BS EN 15154-2:2006) within 10 seconds travel time. Pre-task briefing on emergency eye irrigation procedure (15 minutes continuous flush). Prohibit contact lens wear during application. Annual eye examination for exposed workers.2 × 2 = 4
4. Confined space application without adequate ventilation (oxygen depletion, vapour accumulation)
Harm: Asphyxiation, acute respiratory distress, loss of consciousness, fatal exposure to isocyanate vapours, explosive atmosphere formation with ignition sources
3 × 5 = 15Confined Space Regulations 1997 compliance: Permit-to-Work system mandatory. Pre-entry atmospheric testing (O₂ >19.5%, LEL <10%, MDI <0.02 mg/m³). Forced mechanical ventilation (minimum 6 air changes/hour). Continuous gas monitoring with audible alarms. Standby person and rescue plan. Emergency retrieval equipment. Prohibit lone working. Full-face respirator (BS EN 136) with airline supply for entries >30 minutes.1 × 3 = 3
5. Lack of REACH-mandated diisocyanate training (Regulation EU 2020/1149)
Harm: Non-compliance prosecution, enforcement notice, work stoppage, uncontrolled exposure incidents, worker sensitisation due to inadequate control knowledge, corporate liability
5 × 3 = 15Mandatory documented diisocyanate training (REACH Regulation EU 2020/1149) for all users before first exposure. Training must cover: health hazards, safe handling, PPE selection/use, emergency procedures, exposure monitoring. Refresher training every 5 years minimum. Training records retained for 5 years post-employment. Competency assessment and sign-off by CMIOSH or Occupational Hygienist. Prohibit untrained personnel from handling product. Supplier training certificates verified and audited annually.2 × 2 = 4

3. Step-by-Step Safe Sequence of Operations & Hold-Points

1

REACH Training Verification, COSHH Assessment Review, and LEV Function Test

Preparation and Pre-Task Verification

Verify all operatives hold valid REACH diisocyanate training certificates (Regulation EU 2020/1149) dated within 5 years. Review site-specific COSHH assessment and Method Statement. Inspect LEV system: check airflow indicator (minimum 0.5 m/s capture velocity), verify TExT certificate valid (within 14 months), test audible alarm function. Confirm emergency eyewash station operational (15-second flow test). Establish exclusion zone (3m radius) with barrier tape and signage (GHS07 pictogram, 'Respiratory Sensitiser – PPE Mandatory').

Critical Hold-Point: STOP: Do not proceed if any operative lacks valid REACH diisocyanate training certificate or LEV TExT certificate is expired. Non-compliance is a breach of REACH Regulation EU 2020/1149 and COSHH Regulation 9, exposing employer to enforcement action and workers to irreversible sensitisation.
2

PPE Donning, Fit-Check, and Skin Inspection

Preparation and Pre-Task Verification

Conduct pre-task skin inspection: check hands, forearms, and face for cuts, abrasions, or dermatitis (record findings). Don Type 5/6 coveralls (BS EN ISO 13982-1/BS EN 13034). Don nitrile gloves (BS EN ISO 374-1:2016, >0.38mm thickness) ensuring cuffs overlap coverall sleeves by minimum 100mm. Don safety spectacles (BS EN 166:2001) or full-face visor. If LEV inadequate or confined space work, don half-mask respirator (BS EN 140) with P3+A2 filters and perform positive/negative pressure fit-check. Record PPE issue and fit-check on task permit.

Critical Hold-Point: STOP: Do not proceed if skin damage is present (cuts, eczema, dermatitis) – refer to Occupational Health. Compromised skin barrier dramatically increases sensitisation risk. Do not use barrier creams as substitute for gloves (HSG97 prohibition).
3

Surface Preparation, Cartridge Loading, and LEV Positioning

Application

Clean substrate with isopropanol wipes (ensure adequate ventilation during solvent use). Allow surface to dry completely (typically 5-10 minutes). Position LEV capture hood within 300mm of application point, angled to capture rising vapours. Load Sikaflex-11 FC+ cartridge into application gun, ensuring secure seal. Puncture cartridge seal and attach mixing nozzle (if two-part EBT variant). Purge first 50mm of sealant onto disposable cloth to ensure homogeneous mix. Apply masking tape to define joint edges.

Critical Hold-Point: HOLD POINT: Verify LEV airflow indicator shows adequate capture velocity (>0.5 m/s) before dispensing sealant. Inadequate ventilation will cause MDI vapour accumulation exceeding 0.02 mg/m³ WEL within minutes, triggering acute respiratory sensitisation risk.
4

Controlled Sealant Dispensing and Joint Tooling

Application

Dispense sealant in continuous bead at controlled rate (typically 100-150mm/minute for 10mm joint). Maintain gun nozzle 5-10mm from substrate. Tool joint immediately using wetted spatula or profiling tool (wet with soapy water, not solvent). Remove masking tape within 10 minutes of application while sealant still uncured. Avoid hand contact with uncured sealant – use tools only. Limit continuous application to 2 hours maximum, then take 15-minute break in fresh air area. Dispose of used cartridges and contaminated materials in sealed polyethylene bags labelled 'Isocyanate Waste – H317 Sensitiser'.

Critical Hold-Point: STOP: If sealant contacts skin, do NOT wipe – immediately wash with soap and running water for minimum 15 minutes. Report exposure to supervisor and Occupational Health within 1 hour. Even brief skin contact can trigger irreversible sensitisation. Do not use solvents on skin (increases absorption).
5

Ventilation Maintenance During Cure and Exclusion Zone Management

Post-Application and Curing

Maintain LEV operation or natural ventilation for minimum 24 hours post-application (Sikaflex-11 FC+ cures by moisture reaction, releasing trace MDI vapour). Maintain exclusion zone signage and barriers until sealant fully cured (typically 3-7 days depending on temperature/humidity). Prohibit grinding, cutting, or hot work on cured sealant for 7 days. Monitor work area with portable MDI detector if available (target <0.02 mg/m³). Record application date, batch number, and cure conditions in site diary.

Critical Hold-Point: HOLD POINT: Do not permit unprotected personnel into work area for 24 hours post-application. Curing polyurethane releases MDI vapour which can sensitise unprotected workers. Maintain ventilation and signage until vapour levels confirmed safe by competent person.
6

PPE Removal, Tool Cleaning, and Waste Segregation

Decontamination and Waste Disposal

Remove PPE in controlled sequence to avoid self-contamination: remove outer gloves (turn inside-out), remove coveralls (roll inwards), remove eye protection, remove respirator (if worn), remove inner gloves last (turn inside-out). Dispose of all single-use PPE in sealed polyethylene bags labelled 'Hazardous Waste – Isocyanate Contaminated – EWC 15 02 02*'. Clean reusable tools with isopropanol in well-ventilated area (LEV or outdoors). Wash hands and forearms thoroughly with soap and water. Conduct post-task skin inspection and record findings. Store unused cartridges in original packaging in cool, dry location (<25°C) away from moisture sources.

Critical Hold-Point: STOP: Do not dispose of isocyanate-contaminated waste in general waste streams. Sikaflex waste is classified as hazardous waste (EWC 15 02 02* or 08 04 09*) under Hazardous Waste Regulations 2005. Segregate and consign to licensed hazardous waste carrier with correct documentation. Non-compliance is a criminal offence.

Emergency Rescue, First Aid & Spill Protocol

**SKIN CONTACT:** Immediately remove contaminated clothing and footwear. Wash affected area with soap and copious running water for minimum 15 minutes. Do NOT use solvents on skin. Seek medical attention if irritation, rash, or sensitisation symptoms develop. Report exposure to Occupational Health within 1 hour for surveillance record. **EYE CONTACT:** Immediately irrigate eyes with clean water or eyewash solution for minimum 15 minutes, holding eyelids open. Remove contact lenses if present and easy to do. Seek immediate medical attention – transport to A&E or call 999 if severe pain or vision impairment. **INHALATION:** Remove casualty to fresh air immediately. If breathing is difficult, administer oxygen if trained and equipment available. If breathing stops, commence CPR. Seek immediate medical attention – call 999. Inform paramedics of isocyanate exposure (MDI). Monitor for delayed respiratory symptoms (up to 24 hours post-exposure). **INGESTION:** Do NOT induce vomiting. Rinse mouth thoroughly with water. Give small amounts of water to drink if conscious. Seek immediate medical attention – call 999 or NHS 111. **SPILLAGE:** Evacuate area and establish 5m exclusion zone. Ensure adequate ventilation. Don full PPE (nitrile gloves, respirator with P3+A2 filters, coveralls, eye protection). Absorb liquid with inert material (vermiculite, sand). Place contaminated absorbent in sealed polyethylene bags labelled 'Hazardous Waste – Isocyanate'. Ventilate area for minimum 30 minutes post-cleanup. Dispose via licensed hazardous waste carrier (EWC 08 04 09*). **FIRE:** Sikaflex-11 FC+ is combustible. Thermal decomposition releases toxic isocyanate vapours and nitrogen oxides. Evacuate area. Use water spray, foam, dry powder, or CO₂ extinguishers. Firefighters must wear SCBA and full chemical-protective clothing. Contain contaminated firewater – do not allow to enter drains or watercourses (environmental hazard).

4. UK HSE Compliance FAQs: Sika Sikaflex-11 FC+ & EBT Polyurethane Adhesive Sealant

Do we really need to send every lad who uses Sikaflex on the REACH diisocyanate training course, or can we just do a toolbox talk and sign them off ourselves?

No – a toolbox talk is not sufficient and does not meet the legal requirement. REACH Regulation (EU) 2020/1149, retained in UK law, mandates documented, structured diisocyanate training delivered by a competent provider before any worker handles products containing >0.1% diisocyanate (which Sikaflex-11 FC+ contains as polymeric MDI). The training must cover specific modules on health effects, exposure routes, safe handling, PPE, and emergency procedures, and must be refreshed every 5 years. HSE can prosecute for non-compliance, and your liability insurance may be invalidated if an untrained worker develops occupational asthma or dermatitis. Use an accredited training provider (e.g., BOHS, Sika's own training portal, or industry-recognised e-learning platforms) and retain certificates for 5 years post-employment.

Our LEV system is playing up and the engineer can't come out for another week – can we crack on with the Sikaflex job using just respirators instead, or do we have to down tools?

You can proceed using respiratory protection as an interim control, but only under strict conditions and with documented risk assessment justification. COSHH Regulation 7 establishes a hierarchy: engineering controls (LEV) must be used in preference to PPE (respirators). However, if LEV failure is temporary and the work is urgent, you may use half-mask or full-face respirators with combined P3 particulate and A2 organic vapour filters (BS EN 140, BS EN 143, BS EN 14387), provided: (1) all users are face-fit tested within the last 12 months (quantitative fit-testing preferred); (2) you limit work duration to maximum 2 hours per shift with 15-minute fresh-air breaks; (3) you increase air monitoring (personal sampling) to verify exposure remains below 0.02 mg/m³ WEL; (4) you document the decision and interim controls in your COSHH assessment and Method Statement. Do NOT use respirators as a long-term substitute for LEV – HSE inspectors will issue enforcement notices. Get the LEV repaired and TExT-certified as soon as possible.

One of our subbies has come out in a rash on his hands after using Sikaflex last month – he says it's fine now and wants to carry on working, but should we be worried about him using it again?

Yes – you should be very concerned, and the worker must be referred to Occupational Health immediately before any further isocyanate exposure. The rash is a strong indicator of isocyanate sensitisation (allergic contact dermatitis), which is irreversible and can progress to severe systemic reactions or occupational asthma with repeated exposure. Under COSHH Regulation 11, you must provide health surveillance for workers exposed to respiratory sensitisers and skin sensitisers. The worker should be medically assessed by an occupational health physician or nurse, who will determine fitness to continue isocyanate work. In many cases, sensitised workers must be permanently removed from isocyanate exposure and redeployed to alternative duties – continuing exposure can trigger life-threatening anaphylaxis or chronic respiratory disease. Document the incident in your RIDDOR records (if the worker has been off work for >7 days or diagnosed with occupational disease, it is reportable under RIDDOR 2013). Review your COSHH controls – the sensitisation indicates a failure in skin contact prevention (inadequate gloves, poor hygiene, or lack of training). This is a serious compliance and duty-of-care issue.

5. Operative Toolbox Talk & Competent Person Sign-Off Register

Competent Person & Operative Declaration: By signing below, the Site Supervisor confirms this assessment has been adapted and verified for actual site conditions, and operatives confirm they have attended the pre-start Toolbox Talk for Sika Sikaflex-11 FC+ & EBT Polyurethane Adhesive Sealant and will follow the safe system of work.

Operative / Supervisor Name Trade / Role & CSCS No. Signature Date & Time
1. (Site Supervisor):     
2.     
3.     
4.     
5.     
6.     

Related UK Safety Templates & Risk Assessments